After H3F3A and TP53, the next most frequently mutated gene in DIPG is activin receptor type 1 (ACVR1) [104,108,109], which encodes for a bone morphogenetic protein (BMP) receptor that activates SMAD signalling cascade. The gene discussed is TP53; the disease is diffuse intrinsic pontine glioma.